Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Thierry Boon

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequence

Living Beings

Physiology

Procedures

Molecular Cloning

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
François Violaine; Ottaviani Sabrina; Renkvist Nicolina; Stockis Julie; Schuler Gerold; Thielemans Kris; Colau Didier; Marchand Marie; Boon Thierry; Lucas Sophie; van der Bruggen Pierre
The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
Stockis Julie; Fink Wolfram; François Violaine; Connerotte Thierry; de Smet Charles; Knoops Laurent; van der Bruggen Pierre; Boon Thierry; Coulie Pierre G; Lucas Sophie
Comparison of stable human Treg and Th clones by transcriptional profiling.
Demotte Nathalie; Stroobant Vincent; Courtoy Pierre J; Van Der Smissen Patrick; Colau Didier; Luescher Immanuel F; Hivroz Claire; Nicaise Julie; Squifflet Jean-Luc; Mourad Michel; Godelaine Danièle; Boon Thierry; van der Bruggen Pierre
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Thierry Boon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: François Violaine; Ottaviani Sabrina; Renkvist Nicolina; Stockis Julie; Schuler Gerold; Thielemans Kris; Colau Didier; Marchand Marie; Boon Thierry; Lucas Sophie; van der Bruggen Pierre
The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
Cancer research 2009;69(10):4335-45.
2009: Stockis Julie; Fink Wolfram; François Violaine; Connerotte Thierry; de Smet Charles; Knoops Laurent; van der Bruggen Pierre; Boon Thierry; Coulie Pierre G; Lucas Sophie
Comparison of stable human Treg and Th clones by transcriptional profiling.
European journal of immunology 2009;39(3):869-82.
2008: Demotte Nathalie; Stroobant Vincent; Courtoy Pierre J; Van Der Smissen Patrick; Colau Didier; Luescher Immanuel F; Hivroz Claire; Nicaise Julie; Squifflet Jean-Luc; Mourad Michel; Godelaine Danièle; Boon Thierry; van der Bruggen Pierre
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.
Immunity 2008;28(3):414-24.
2008: Carrasco Javier; Van Pel Aline; Neyns Bart; Lethé Bernard; Brasseur Francis; Renkvist Nicolina; van der Bruggen Pierre; van Baren Nicolas; Paulus Robert; Thielemans Kris; Boon Thierry; Godelaine Danièle
Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(5):3585-93.
2007: Godelaine Danièle; Carrasco Javier; Brasseur Francis; Neyns Bart; Thielemans Kris; Boon Thierry; Van Pel Aline
A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44.
Cancer immunology, immunotherapy : CII 2007;56(6):753-9.
2007: van der Bruggen Pierre; Traversari Catia; Chomez Patrick; Lurquin Christophe; De Plaen Etienne; Van den Eynde Benoît J; Knuth Alexander; Boon Thierry
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(5):2617-21.
2007: So Tomoko; Hanagiri Takeshi; Chapiro Jacques; Colau Didier; Brasseur Francis; Yasumoto Kosei; Boon Thierry; Coulie Pierre G
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.
Cancer immunology, immunotherapy : CII 2007;56(2):259-69.
2006: Carrasco Javier; Godelaine Danièle; Van Pel Aline; Boon Thierry; van der Bruggen Pierre
CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation.
Blood 2006;108(9):2897-905.
2006: Sun Zhaojun; Lethé Bernard; Zhang Yi; Russo Vincenzo; Colau Didier; Stroobant Vincent; Boon Thierry; van der Bruggen Pierre
A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors.
Cancer immunology, immunotherapy : CII 2006;55(6):644-52.
2006: Loriot Axelle; De Plaen Etienne; Boon Thierry; De Smet Charles
Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells.
The Journal of biological chemistry 2006;281(15):10118-26.
2006: Takenoyama Mitsuhiro; Baurain Jean-Françis; Yasuda Manabu; So Tomoko; Sugaya Masakazu; Hanagiri Takeshi; Sugio Kenji; Yasumoto Kosei; Boon Thierry; Coulie Pierre G
A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma.
International journal of cancer. Journal international du cancer 2006;118(8):1992-7.
2006: Hanagiri Takeshi; van Baren Nicolas; Neyns Bart; Boon Thierry; Coulie Pierre G
Analysis of a rare melanoma patient with a spontaneous CTL response to a MAGE-A3 peptide presented by HLA-A1.
Cancer immunology, immunotherapy : CII 2006;55(2):178-84.
2006: Chapiro Jacques; Claverol Stéphane; Piette Fanny; Ma Wenbin; Stroobant Vincent; Guillaume Benoît; Gairin Jean-Edouard; Morel Sandra; Burlet-Schiltz Odile; Monsarrat Bernard; Boon Thierry; Van den Eynde Benoît J
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(2):1053-61.
2006: Boon Thierry; Coulie Pierre G; Van den Eynde Benoît J; van der Bruggen Pierre
Human T cell responses against melanoma.
Annual review of immunology 2006;24():175-208.
2005: Zammatteo Nathalie; Davril Caroline; Brasseur Francis; Hamels Sandrine; De Plaen Etienne; Boon Thierry; Remacle José
Unambiguous identification of the expressed MAGE-A genes on a DNA microarray.
Clinical chemistry 2005;51(12):2420-1.
2005: van Baren Nicolas; Bonnet Marie-Claude; Dréno Brigitte; Khammari Amir; Dorval Thierry; Piperno-Neumann Sophie; Liénard Danielle; Speiser Daniel; Marchand Marie; Brichard Vincent G; Escudier Bernard; Négrier Sylvie; Dietrich Pierre-Yves; Maraninchi Dominique; Osanto Susanne; Meyer Ralf G; Ritter Gerd; Moingeon Philippe; Tartaglia Jim; van der Bruggen Pierre; Coulie Pierre G; Boon Thierry
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(35):9008-21.
2005: Ottaviani Sabrina; Zhang Yi; Boon Thierry; van der Bruggen Pierre
A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells.
Cancer immunology, immunotherapy : CII 2005;54(12):1214-20.
2005: Kruit Wim H J; van Ojik Heidi H; Brichard Vincent G; Escudier Bernard; Dorval Thierry; Dréno Brigitte; Patel Poulam; van Baren Nicolas; Avril Marie-Françoise; Piperno Sophie; Khammari Amir; Stas Marguerite; Ritter Gerd; Lethé Bernard; Godelaine Danièle; Brasseur Francis; Zhang Yi; van der Bruggen Pierre; Boon Thierry; Eggermont Alexander M M; Marchand Marie
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma.
International journal of cancer. Journal international du cancer 2005;117(4):596-604.
2005: Zhang Yi; Renkvist Nicolina; Sun Zhaojun; Schuler-Thurner Beatrice; Glaichenhaus Nicolas; Schuler Gerold; Boon Thierry; van der Bruggen Pierre; Colau Didier
A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells.
European journal of immunology 2005;35(4):1066-75.
2005: Zhang Yi; Sun Zhaojun; Nicolay Hugues; Meyer Ralf G; Renkvist Nicolina; Stroobant Vincent; Corthals Jurgen; Carrasco Javier; Eggermont Alexander M M; Marchand Marie; Thielemans Kris; Wölfel Thomas; Boon Thierry; van der Bruggen Pierre
Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):2404-11.
2005: Lurquin Christophe; Lethé Bernard; De Plaen Etienne; Corbière Véronique; Théate Ivan; van Baren Nicolas; Coulie Pierre G; Boon Thierry
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.
The Journal of experimental medicine 2005;201(2):249-57.
2005: Germeau Catherine; Ma Wenbin; Schiavetti Francesca; Lurquin Christophe; Henry Emmanuelle; Vigneron Nathalie; Brasseur Francis; Lethé Bernard; De Plaen Etienne; Velu Thierry; Boon Thierry; Coulie Pierre G
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.
The Journal of experimental medicine 2005;201(2):241-8.
2005: Brenner Carmen; Deplus Rachel; Didelot Céline; Loriot Axelle; Viré Emmanuelle; De Smet Charles; Gutierrez Arantxa; Danovi Davide; Bernard David; Boon Thierry; Pelicci Pier Giuseppe; Amati Bruno; Kouzarides Tony; de Launoit Yvan; Di Croce Luciano; Fuks François
Myc represses transcription through recruitment of DNA methyltransferase corepressor.
The EMBO journal 2005;24(2):336-46.
2004: Lonchay Christophe; van der Bruggen Pierre; Connerotte Thierry; Hanagiri Takeshi; Coulie Pierre; Colau Didier; Lucas Sophie; Van Pel Aline; Thielemans Kris; van Baren Nicolas; Boon Thierry
Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.
Proceedings of the National Academy of Sciences of the United States of America 2004;101 Suppl 2():14631-8.
2004: De Smet Charles; Loriot Axelle; Boon Thierry
Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells.
Molecular and cellular biology 2004;24(11):4781-90.
2004: Corbière V; Nicolay H; Russo V; Stroobant V; Brichard V; Boon T; van der Bruggen P
Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors.
Tissue antigens 2004;63(5):453-7.
2004: Ma Wenbin; Germeau Catherine; Vigneron Nathalie; Maernoudt Anne-Sophie; Morel Sandra; Boon Thierry; Coulie Pierre G; Van den Eynde Benoît J
Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.
International journal of cancer. Journal international du cancer 2004;109(5):698-702.
2004: Vigneron Nathalie; Stroobant Vincent; Chapiro Jacques; Ooms Annie; Degiovanni Gérard; Morel Sandra; van der Bruggen Pierre; Boon Thierry; Van den Eynde Benoît J
An antigenic peptide produced by peptide splicing in the proteasome.
Science (New York, N.Y.) 2004;304(5670):587-90.
2004: Vialle-Castellano Alexandra; Laduron Sandra; De Plaen Etienne; Jost Edgar; Dupont Sophie; Ameye Geneviève; Michaux Lucienne; Coulie Pierre; Olive Daniel; Boon Thierry; van Baren Nicolas
A gene expressed exclusively in acute B lymphoblastic leukemias.
Genomics 2004;83(1):85-94.
2004: Laduron Sandra; Deplus Rachel; Zhou Sifang; Kholmanskikh Olga; Godelaine Danièle; De Smet Charles; Hayward S Diane; Fuks François; Boon Thierry; De Plaen Etienne
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription.
Nucleic acids research 2004;32(14):4340-50.
2003: Vantomme Valérie; Boël Pascale; De Plaen Etienne; Boon Thierry; van der Bruggen Pierre
A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cw16.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():17.
2003: Kobayashi T; Lonchay C; Colau D; Demotte N; Boon T; van der Bruggen P
New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells.
Tissue antigens 2003;62(5):426-32.
2003: Karanikas Vaios; Lurquin Christophe; Colau Didier; van Baren Nicolas; De Smet Charles; Lethé Bernard; Connerotte Thierry; Corbière Véronique; Demoitié Marie-Ange; Liénard Danielle; Dréno Brigitte; Velu Thierry; Boon Thierry; Coulie Pierre G
Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(9):4898-904.
2003: Godelaine Danièle; Carrasco Javier; Lucas Sophie; Karanikas Vaios; Schuler-Thurner Beatrice; Coulie Pierre G; Schuler Gerold; Boon Thierry; Van Pel Aline
Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(9):4893-7.
2003: Uyttenhove Catherine; Pilotte Luc; Théate Ivan; Stroobant Vincent; Colau Didier; Parmentier Nicolas; Boon Thierry; Van den Eynde Benoît J
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.
Nature medicine 2003;9(10):1269-74.
2003: Zhang Yi; Chaux Pascal; Stroobant Vincent; Eggermont Alexander M M; Corthals Jurgen; Maillère Bernard; Thielemans Kris; Marchand Marie; Boon Thierry; Van Der Bruggen Pierre
A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(1):219-25.
2003: Loriot Axelle; Boon Thierry; De Smet Charles
Five new human cancer-germline genes identified among 12 genes expressed in spermatogonia.
International journal of cancer. Journal international du cancer 2003;105(3):371-6.
2003: Boon Thierry; van Baren Nicolas
Immunosurveillance against cancer and immunotherapy--synergy or antagonism?
The New England journal of medicine 2003;348(3):252-4.
2003: Marchand M; Punt C J A; Aamdal S; Escudier B; Kruit W H J; Keilholz U; Håkansson L; van Baren N; Humblet Y; Mulders P; Avril M-F; Eggermont A M M; Scheibenbogen C; Uiters J; Wanders J; Delire M; Boon T; Stoter G
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report.
European journal of cancer (Oxford, England : 1990) 2003;39(1):70-7.
2002: Van Der Bruggen Pierre; Zhang Yi; Chaux Pascal; Stroobant Vincent; Panichelli Christophe; Schultz Erwin S; Chapiro Jacques; Van Den Eynde Benoît J; Brasseur Francis; Boon Thierry
Tumor-specific shared antigenic peptides recognized by human T cells.
Immunological reviews 2002;188():51-64.
2002: Coulie Pierre G; Karanikas Vaios; Lurquin Christophe; Colau Didier; Connerotte Thierry; Hanagiri Takeshi; Van Pel Aline; Lucas Sophie; Godelaine Danièle; Lonchay Christophe; Marchand Marie; Van Baren Nicolas; Boon Thierry
Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.
Immunological reviews 2002;188():33-42.
2002: Schiavetti Francesca; Thonnard Joëlle; Colau Didier; Boon Thierry; Coulie Pierre G
A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.
Cancer research 2002;62(19):5510-6.
2002: Bilsborough Janine; Uyttenhove Catherine; Colau Didier; Bousso Philippe; Libert Claude; Weynand Birgit; Boon Thierry; van den Eynde Benoit J
TNF-mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(6):3053-60.
2002: Bilsborough J; Panichelli C; Duffour M-T; Warnier G; Lurquin C; Schultz E S; Thielemans K; Corthals J; Boon T; van der Bruggen P
A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18.
Tissue antigens 2002;60(1):16-24.
2002: Demotte Nathalie; Colau Didier; Ottaviani Sabrina; Godelaine Danièle; Van Pel Aline; Boon Thierry; van der Bruggen Pierre
A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling.
European journal of immunology 2002;32(6):1688-97.
2002: Schultz Erwin S; Chapiro Jacques; Lurquin Christophe; Claverol Stéphane; Burlet-Schiltz Odile; Warnier Guy; Russo Vincenzo; Morel Sandra; Lévy Frédéric; Boon Thierry; Van den Eynde Benoît J; van der Bruggen Pierre
The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome.
The Journal of experimental medicine 2002;195(4):391-9.
2002: Zammatteo Nathalie; Lockman Laurence; Brasseur Francis; De Plaen Etienne; Lurquin Christophe; Lobert Pierre-Emmanuel; Hamels Sandrine; Boon Thierry; Remacle José
DNA microarray to monitor the expression of MAGE-A genes.
Clinical chemistry 2002;48(1):25-34.
2001: Coulie P G; Karanikas V; Colau D; Lurquin C; Landry C; Marchand M; Dorval T; Brichard V; Boon T
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(18):10290-5.
2001: Chomez P; De Backer O; Bertrand M; De Plaen E; Boon T; Lucas S
An overview of the MAGE gene family with the identification of all human members of the family.
Cancer research 2001;61(14):5544-51.
2001: Chaux P; Lethé B; Van Snick J; Corthals J; Schultz E S; Cambiaso C L; Boon T; van der Bruggen P
A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells.
European journal of immunology 2001;31(6):1910-6.
2001: Probst-Kepper M; Stroobant V; Kridel R; Gaugler B; Landry C; Brasseur F; Cosyns J P; Weynand B; Boon T; Van Den Eynde B J
An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes.
The Journal of experimental medicine 2001;193(10):1189-98.
2001: Karanikas V; Colau D; Baurain J F; Chiari R; Thonnard J; Gutierrez-Roelens I; Goffinet C; Van Schaftingen E V; Weynants P; Boon T; Coulie P G
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival.
Cancer research 2001;61(9):3718-24.
2001: Schultz E S; Zhang Y; Knowles R; Tine J; Traversari C; Boon T; van der Bruggen P
A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.
Tissue antigens 2001;57(2):103-9.
2001: Van Pel A; De Plaen E; Duffour M T; Warnier G; Uyttenhove C; Perricaudet M; Boon T
Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes.
Cancer immunology, immunotherapy : CII 2001;49(11):593-602.
2000: Schultz E S; Lethé B; Cambiaso C L; Van Snick J; Chaux P; Corthals J; Heirman C; Thielemans K; Boon T; van der Bruggen P
A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.
Cancer research 2000;60(22):6272-5.
2000: Chiari R; Hames G; Stroobant V; Texier C; Maillère B; Boon T; Coulie P G
Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules.
Cancer research 2000;60(17):4855-63.
2000: Clotman F; De Backer O; De Plaen E; Boon T; Picard J
Cell- and stage-specific expression of mage genes during mouse spermatogenesis.
Mammalian genome : official journal of the International Mammalian Genome Society 2000;11(8):696-9.
2000: Martelange V; De Smet C; De Plaen E; Lurquin C; Boon T
Identification on a human sarcoma of two new genes with tumor-specific expression.
Cancer research 2000;60(14):3848-55.
2000: Lucas S; De Plaen E; Boon T
MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression.
International journal of cancer. Journal international du cancer 2000;87(1):55-60.
2000: Landry C; Brasseur F; Spagnoli G C; Marbaix E; Boon T; Coulie P; Godelaine D
Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4.
International journal of cancer. Journal international du cancer 2000;86(6):835-41.
2000: Baurain J F; Colau D; van Baren N; Landry C; Martelange V; Vikkula M; Boon T; Coulie P G
High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(11):6057-66.
2000: Heidecker L; Brasseur F; Probst-Kepper M; Guéguen M; Boon T; Van den Eynde B J
Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(11):6041-5.
2000: Huang L Q; Boon T; Van Pel A
Identification of a novel HLA-Cw*05 allele, Cw*0503.
Tissue antigens 2000;55(5):473-4.
2000: Morel S; Lévy F; Burlet-Schiltz O; Brasseur F; Probst-Kepper M; Peitrequin A L; Monsarrat B; Van Velthoven R; Cerottini J C; Boon T; Gairin J E; Van den Eynde B J
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.
Immunity 2000;12(1):107-17.
1999: Van Den Eynde B J; Gaugler B; Probst-Kepper M; Michaux L; Devuyst O; Lorge F; Weynants P; Boon T
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription.
The Journal of experimental medicine 1999;190(12):1793-800.
1999: De Smet C; Lurquin C; Lethé B; Martelange V; Boon T
DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.
Molecular and cellular biology 1999;19(11):7327-35.
1999: Serrano A; Lethé B; Delroisse J M; Lurquin C; De Plaen E; Brasseur F; Rimoldi D; Boon T
Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
International journal of cancer. Journal international du cancer 1999;83(5):664-9.
1999: Duffour M T; Chaux P; Lurquin C; Cornelis G; Boon T; van der Bruggen P
A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes.
European journal of immunology 1999;29(10):3329-37.
1999: Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis G R; Boon T; van der Bruggen P
Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(5):2928-36.
1999: Lucas S; Brasseur F; Boon T
A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.
Cancer research 1999;59(16):4100-3.
1999: van Baren N; Brasseur F; Godelaine D; Hames G; Ferrant A; Lehmann F; André M; Ravoet C; Doyen C; Spagnoli G C; Bakkus M; Thielemans K; Boon T
Genes encoding tumor-specific antigens are expressed in human myeloma cells.
Blood 1999;94(4):1156-64.
1999: De Backer O; Arden K C; Boretti M; Vantomme V; De Smet C; Czekay S; Viars C S; De Plaen E; Brasseur F; Chomez P; Van den Eynde B; Boon T; van der Bruggen P
Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.
Cancer research 1999;59(13):3157-65.
1999: Silla S; Fallarino F; Boon T; Uyttenhove C
Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL.
European cytokine network 1999;10(2):181-90.
1999: Huang L Q; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A
Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(11):6849-54.
1999: Bilsborough J; Van Pel A; Uyttenhove C; Boon T; Van den Eynde B J
Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3534-40.
1999: Chaux P; Vantomme V; Stroobant V; Thielemans K; Corthals J; Luiten R; Eggermont A M; Boon T; van der Bruggen P
Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.
The Journal of experimental medicine 1999;189(5):767-78.
1999: Fallarino F; Uyttenhove C; Boon T; Gajewski T F
Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12.
International journal of cancer. Journal international du cancer 1999;80(2):324-33.
1999: Marchand M; van Baren N; Weynants P; Brichard V; Dréno B; Tessier M H; Rankin E; Parmiani G; Arienti F; Humblet Y; Bourlond A; Vanwijck R; Liénard D; Beauduin M; Dietrich P Y; Russo V; Kerger J; Masucci G; Jäger E; De Greve J; Atzpodien J; Brasseur F; Coulie P G; van der Bruggen P; Boon T
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1.
International journal of cancer. Journal international du cancer 1999;80(2):219-30.
1999: De Plaen E; De Backer O; Arnaud D; Bonjean B; Chomez P; Martelange V; Avner P; Baldacci P; Babinet C; Hwang S Y; Knowles B; Boon T
A new family of mouse genes homologous to the human MAGE genes.
Genomics 1999;55(2):176-84.
1999: Weynants P; Thonnard J; Marchand M; Delos M; Boon T; Coulie P G
Derivation of tumor-specific cytolytic T-cell clones from two lung cancer patients with long survival.
American journal of respiratory and critical care medicine 1999;159(1):55-62.
1998: Benitez R; Godelaine D; Lopez-Nevot M A; Brasseur F; Jiménez P; Marchand M; Oliva M R; van Baren N; Cabrera T; Andry G; Landry C; Ruiz-Cabello F; Boon T; Garrido F
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.
Tissue antigens 1998;52(6):520-9.
1998: Brändle D; Bilsborough J; Rülicke T; Uyttenhove C; Boon T; Van den Eynde B J
The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.
European journal of immunology 1998;28(12):4010-9.
1998: van Baren N; Chambost H; Ferrant A; Michaux L; Ikeda H; Millard I; Olive D; Boon T; Coulie P G
PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells.
British journal of haematology 1998;102(5):1376-9.
1998: Chaux P; Vantomme V; Coulie P; Boon T; van der Bruggen P
Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer.
International journal of cancer. Journal international du cancer 1998;77(4):538-42.
1998: Guéguen M; Patard J J; Gaugler B; Brasseur F; Renauld J C; Van Cangh P J; Boon T; Van den Eynde B J
An antigen recognized by autologous CTLs on a human bladder carcinoma.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):6188-94.
1998: Lethé B; Lucas S; Michaux L; De Smet C; Godelaine D; Serrano A; De Plaen E; Boon T
LAGE-1, a new gene with tumor specificity.
International journal of cancer. Journal international du cancer 1998;76(6):903-8.
1998: Lucas S; De Smet C; Arden K C; Viars C S; Lethé B; Lurquin C; Boon T
Identification of a new MAGE gene with tumor-specific expression by representational difference analysis.
Cancer research 1998;58(4):743-52.
1998: Schneider J; Brichard V; Boon T; Meyer zum Büschenfelde K H; Wölfel T
Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.
International journal of cancer. Journal international du cancer 1998;75(3):451-8.
1997: Lurquin C; De Smet C; Brasseur F; Muscatelli F; Martelange V; De Plaen E; Brasseur R; Monaco A P; Boon T
Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins.
Genomics 1997;46(3):397-408.
1997: De Smet C; Martelange V; Lucas S; Brasseur F; Lurquin C; Boon T
Identification of human testis-specific transcripts and analysis of their expression in tumor cells.
Biochemical and biophysical research communications 1997;241(3):653-7.
1997: Fallarino F; Ashikari A; Boon T; Gajewski T F
Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.
International immunology 1997;9(9):1259-69.
1997: Lethé B; van der Bruggen P; Brasseur F; Boon T
MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte.
Melanoma research 1997;7 Suppl 2():S83-8.
1997: Mandruzzato S; Brasseur F; Andry G; Boon T; van der Bruggen P
A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.
The Journal of experimental medicine 1997;186(5):785-93.
1997: De Plaen E; Lurquin C; Lethé B; van der Bruggen P; Brichard V; Renauld J C; Coulie P; Van Pel A; Boon T
Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes.
Methods (San Diego, Calif.) 1997;12(2):125-42.
1997: Coulie P G; Van den Eynde B J; van der Bruggen P; Van Pel A; Boon T
Antigens recognized by T-lymphocytes on human tumours.
Biochemical Society transactions 1997;25(2):544-8.
1997: De Plaen E; Naerhuyzen B; De Smet C; Szikora J P; Boon T
Alternative promoters of gene MAGE4a.
Genomics 1997;40(2):305-13.
1997: Ikeda H; Lethé B; Lehmann F; van Baren N; Baurain J F; de Smet C; Chambost H; Vitale M; Moretta A; Boon T; Coulie P G
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor.
Immunity 1997;6(2):199-208.
1997: Uyttenhove C; Godfraind C; Lethé B; Amar-Costesec A; Renauld J C; Gajewski T F; Duffour M T; Warnier G; Boon T; Van den Eynde B J
The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
International journal of cancer. Journal international du cancer 1997;70(3):349-56.
1997: De Smet C; Lurquin C; De Plaen E; Brasseur F; Zarour H; De Backer O; Coulie P G; Boon T
Genes coding for melanoma antigens recognised by cytolytic T lymphocytes.
Eye (London, England) 1997;11 ( Pt 2)():243-8.
1996: Warnier G; Duffour M T; Uyttenhove C; Gajewski T F; Lurquin C; Haddada H; Perricaudet M; Boon T
Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A.
International journal of cancer. Journal international du cancer 1996;67(2):303-10.
1996: Zarour H; De Smet C; Lehmann F; Marchand M; Lethé B; Romero P; Boon T; Renauld J C
The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100.
The Journal of investigative dermatology 1996;107(1):63-7.
1996: De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(14):7149-53.
1996: Brändle D; Brasseur F; Weynants P; Boon T; Van den Eynde B
A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.
The Journal of experimental medicine 1996;183(6):2501-8.
1996: Mulcahy K A; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie I G; Murray A K; McIntyre C A; Platts K E; Leyvraz S; Boon T; Rees R C
Infrequent expression of the MAGE gene family in uveal melanomas.
International journal of cancer. Journal international du cancer 1996;66(6):738-42.
1996: Gajewski T F; Fallarino F; Uyttenhove C; Boon T
Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(8):2909-17.
1996: Boon T; van der Bruggen P
Human tumor antigens recognized by T lymphocytes.
The Journal of experimental medicine 1996;183(3):725-9.
1996: Guilloux Y; Lucas S; Brichard V G; Van Pel A; Viret C; De Plaen E; Brasseur F; Lethé B; Jotereau F; Boon T
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.
The Journal of experimental medicine 1996;183(3):1173-83.
1996: Skipper J C; Hendrickson R C; Gulden P H; Brichard V; Van Pel A; Chen Y; Shabanowitz J; Wolfel T; Slingluff C L; Boon T; Hunt D F; Engelhard V H
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.
The Journal of experimental medicine 1996;183(2):527-34.
1996: Fallarino F; Uyttenhove C; Boon T; Gajewski T F
Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):1095-100.
1996: Brichard V G; Herman J; Van Pel A; Wildmann C; Gaugler B; Wölfel T; Boon T; Lethé B
A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
European journal of immunology 1996;26(1):224-30.
1996: Gaugler B; Brouwenstijn N; Vantomme V; Szikora J P; Van der Spek C W; Patard J J; Boon T; Schrier P; Van den Eynde B J
A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma.
Immunogenetics 1996;44(5):323-30.
1996: Herman J; van der Bruggen P; Luescher I F; Mandruzzato S; Romero P; Thonnard J; Fleischhauer K; Boon T; Coulie P G
A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.
Immunogenetics 1996;43(6):377-83.
1996: Chomez P; Williams R; De Backer O; Boon T; Vennström B
The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation.
Immunogenetics 1996;43(1-2):97-100.
1995: Grohmann U; Bianchi R; Fioretti M C; Fallarino F; Binaglia L; Uyttenhove C; Van Pel A; Boon T; Puccetti P
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide.
European journal of immunology 1995;25(10):2797-802.
1995: Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
The Journal of experimental medicine 1995;182(3):689-98.
1995: Van den Eynde B; Gaugler B; van der Bruggen P; Coulie P; Brichard V; Boon T
Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.
Biochemical Society transactions 1995;23(3):681-6.
1995: Coulie P G; Lehmann F; Lethé B; Herman J; Lurquin C; Andrawiss M; Boon T
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(17):7976-80.
1995: De Backer O; Verheyden A M; Martin B; Godelaine D; De Plaen E; Brasseur R; Avner P; Boon T
Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes.
Genomics 1995;28(1):74-83.
1995: Van Pel A; van der Bruggen P; Coulie P G; Brichard V G; Lethé B; van den Eynde B; Uyttenhove C; Renauld J C; Boon T
Genes coding for tumor antigens recognized by cytolytic T lymphocytes.
Immunological reviews 1995;145():229-50.
1995: Gajewski T F; Renauld J C; Van Pel A; Boon T
Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):5637-48.
1995: Brichard V G; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
European journal of immunology 1995;25(3):664-71.
1995: Boël P; Wildmann C; Sensi M L; Brasseur R; Renauld J C; Coulie P; Boon T; van der Bruggen P
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes.
Immunity 1995;2(2):167-75.
1995: Lehmann F; Marchand M; Hainaut P; Pouillart P; Sastre X; Ikeda H; Boon T; Coulie P G
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.
European journal of immunology 1995;25(2):340-7.
1995: De Smet C; Courtois S J; Faraoni I; Lurquin C; Szikora J P; De Backer O; Boon T
Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.
Immunogenetics 1995;42(4):282-90.
1994: van der Bruggen P; Bastin J; Gajewski T; Coulie P G; Boël P; De Smet C; Traversari C; Townsend A; Boon T
A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
European journal of immunology 1994;24(12):3038-43.
1994: de Bergeyck V; De Plaen E; Chomez P; Boon T; Van Pel A
An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia.
European journal of immunology 1994;24(9):2203-12.
1994: van der Bruggen P; Szikora J P; Boël P; Wildmann C; Somville M; Sensi M; Boon T
Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.
European journal of immunology 1994;24(9):2134-40.
1994: Coulie P G; Brichard V; Van Pel A; Wölfel T; Schneider J; Traversari C; Mattei S; De Plaen E; Lurquin C; Szikora J P; Renauld J C; Boon T
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
The Journal of experimental medicine 1994;180(1):35-42.
1994: Puccetti P; Bianchi R; Fioretti M C; Ayroldi E; Uyttenhove C; Van Pel A; Boon T; Grohmann U
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity.
European journal of immunology 1994;24(6):1446-52.
1994: Wölfel T; Van Pel A; Brichard V; Schneider J; Seliger B; Meyer zum Büschenfelde K H; Boon T
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.
European journal of immunology 1994;24(3):759-64.
1994: Weynants P; Lethé B; Brasseur F; Marchand M; Boon T
Expression of mage genes by non-small-cell lung carcinomas.
International journal of cancer. Journal international du cancer 1994;56(6):826-9.
1994: Gaugler B; Van den Eynde B; van der Bruggen P; Romero P; Gaforio J J; De Plaen E; Lethé B; Brasseur F; Boon T
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
The Journal of experimental medicine 1994;179(3):921-30.
1994: De Smet C; Lurquin C; van der Bruggen P; De Plaen E; Brasseur F; Boon T
Sequence and expression pattern of the human MAGE2 gene.
Immunogenetics 1994;39(2):121-9.
1994: Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Important advances in oncology 1994;():53-69.
1994: Boon T; Van den Eynde B; Hirsch H; Moroni C; De Plaen E; van der Bruggen P; De Smet C; Lurquin C; Szikora J P; De Backer O
Genes coding for tumor-specific rejection antigens.
Cold Spring Harbor symposia on quantitative biology 1994;59():617-22.
1993: Wölfel T; Hauer M; Klehmann E; Brichard V; Ackermann B; Knuth A; Boon T; Meyer Zum Büschenfelde K H
Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL).
International journal of cancer. Journal international du cancer 1993;55(2):237-44.
1993: Coulie P; Weynants P; Muller C; Lehmann F; Herman J; Baurain J F; Boon T
Genes coding for antigens recognized on human tumors by autologous cytolytic T lymphocytes.
Annals of the New York Academy of Sciences 1993;690():113-9.
1993: Brichard V; Van Pel A; Wölfel T; Wölfel C; De Plaen E; Lethé B; Coulie P; Boon T
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
The Journal of experimental medicine 1993;178(2):489-95.
1993: Coulie P G; Weynants P; Lehmann F; Herman J; Brichard V; Wölfel T; Van Pel A; De Plaen E; Brasseur F; Boon T
Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(2):104-9.
1993: Boon T
Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.
International journal of cancer. Journal international du cancer 1993;54(2):177-80.
1993: Szikora J P; Van Pel A; Boon T
Tum- mutation P35B generates the MHC-binding site of a new antigenic peptide.
Immunogenetics 1993;37(2):135-8.
1992: Brasseur F; Marchand M; Vanwijck R; Hérin M; Lethé B; Chomez P; Boon T
Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors.
International journal of cancer. Journal international du cancer 1992;52(5):839-41.
1992: Traversari C; van der Bruggen P; Luescher I F; Lurquin C; Chomez P; Van Pel A; De Plaen E; Amar-Costesec A; Boon T
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
The Journal of experimental medicine 1992;176(5):1453-7.
1992: Lethé B; van den Eynde B; van Pel A; Corradin G; Boon T
Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide.
European journal of immunology 1992;22(9):2283-8.
1992: Coulie P G; Somville M; Lehmann F; Hainaut P; Brasseur F; Devos R; Boon T
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells.
International journal of cancer. Journal international du cancer 1992;50(2):289-97.
1992: Boon T
Toward a genetic analysis of tumor rejection antigens.
Advances in cancer research 1992;58():177-210.
1992: Chomez P; De Plaen E; Van Pel A; De Smet C; Szikora J P; Lurquin C; Lebacq-Verheyden A M; Boon T
Efficient expression of tum- antigen P91A by transfected subgenic fragments.
Immunogenetics 1992;35(4):241-52.
1992: Traversari C; van der Bruggen P; Van den Eynde B; Hainaut P; Lemoine C; Ohta N; Old L; Boon T
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes.
Immunogenetics 1992;35(3):145-52.
1992: Boon T; De Plaen E; Lurquin C; Van den Eynde B; van der Bruggen P; Traversari C; Amar-Costesec A; Van Pel A
Identification of tumour rejection antigens recognized by T lymphocytes.
Cancer surveys 1992;13():23-37.
1991: van der Bruggen P; Traversari C; Chomez P; Lurquin C; De Plaen E; Van den Eynde B; Knuth A; Boon T
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
Science (New York, N.Y.) 1991;254(5038):1643-7.
1991: Van Pel A; Warnier G; Van den Eynde B; Lethé B; Lurquin C; Boon T
Tum- antigens, TSTA, and T cell immune surveillance.
Annals of the New York Academy of Sciences 1991;636():43-51.
1991: Van den Eynde B; Lethé B; Van Pel A; De Plaen E; Boon T
The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
The Journal of experimental medicine 1991;173(6):1373-84.
1990: Degiovanni G; Hainaut P; Lahaye T; Weynants P; Boon T
Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells.
European journal of immunology 1990;20(8):1865-8.
1990: Sibille C; Chomez P; Wildmann C; Van Pel A; De Plaen E; Maryanski J L; de Bergeyck V; Boon T
Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.
The Journal of experimental medicine 1990;172(1):35-45.
1990: Szikora J P; Van Pel A; Brichard V; André M; Van Baren N; Henry P; De Plaen E; Boon T
Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele.
The EMBO journal 1990;9(4):1041-50.
1989: Van den Eynde B; Hainaut P; Hérin M; Knuth A; Lemoine C; Weynants P; van der Bruggen P; Fauchet R; Boon T
Presence on a human melanoma of multiple antigens recognized by autologous CTL.
International journal of cancer. Journal international du cancer 1989;44(4):634-40.
1989: Boon T; Van Pel A; De Plaen E
Tum- transplantation antigens, point mutations, and antigenic peptides: a model for tumor-specific transplantation antigens?
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1989;1(1):25-8.
1989: Lurquin C; Van Pel A; Mariamé B; De Plaen E; Szikora J P; Janssens C; Reddehase M J; Lejeune J; Boon T
Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells.
Cell 1989;58(2):293-303.
1989: Boon T; Szikora J P; De Plaen E; Wölfel T; Van Pel A
Cloning and characterization of genes coding for tum- transplantation antigens.
Journal of autoimmunity 1989;2 Suppl():109-14.
1989: Knuth A; Wölfel T; Klehmann E; Boon T; Meyer zum Büschenfelde K H
Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(8):2804-8.
1989: Boon T; Van Pel A
T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis.
Immunogenetics 1989;29(2):75-9.
1989: Boon T; Van Pel A; De Plaen E; Chomez P; Lurquin C; Szikora J P; Sibille C; Mariamé B; Van den Eynde B; Lethé B
Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression.
Cold Spring Harbor symposia on quantitative biology 1989;54 Pt 1():587-96.
1988: Degiovanni G; Lahaye T; Hérin M; Hainaut P; Boon T
Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.
European journal of immunology 1988;18(5):671-6.
1988: De Plaen E; Lurquin C; Van Pel A; Mariamé B; Szikora J P; Wölfel T; Sibille C; Chomez P; Boon T
Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(7):2274-8.
1988: Van Snick J; Cayphas S; Szikora J P; Renauld J C; Van Roost E; Boon T; Simpson R J
cDNA cloning of murine interleukin-HP1: homology with human interleukin 6.
European journal of immunology 1988;18(2):193-7.
1988: Van Pel A; De Plaen E; Lurquin C; Van den Eynde B; Lethé B; Hainaut P; Lemoine C; Boon T
Identification of genes encoding T cell defined tum- antigens.
Princess Takamatsu symposia 1988;19():255-63.
1987: Hérin M; Lemoine C; Weynants P; Vessière F; Van Pel A; Knuth A; Devos R; Boon T
Production of stable cytolytic T-cell clones directed against autologous human melanoma.
International journal of cancer. Journal international du cancer 1987;39(3):390-6.
1986: Boon T; Van Pel A; De Plaen E; Vessière F
Mutagen-induced antigenic variants of tumor cells.
Symposium on Fundamental Cancer Research 1986;38():139-48.
1983: Van Pel A; Vessière F; Boon T
Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.
The Journal of experimental medicine 1983;157(6):1992-2001.
1982: Vessière F; Georlette M; Warnier G; Leclerc J C; Van Pel A; Boon T
Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes.
European journal of cancer & clinical oncology 1982;18(9):867-74.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Thierry Boon

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Concepts & Ideas

Genes & Molecular Sequences

Living Beings

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Thierry Boon (preview)

All Publications